| Old Articles: <Older 1141-1150 Newer> |
|---|
 |
IEEE Spectrum
October 2006
Philip E. Ross |
When Engineers' Genes Collide Could modern patterns of marriage be concentrating the genes that predispose people to autism?   |
Reason
October 2006
Kerry Howley |
Ova for Sale The art of the deal in the gray market for human eggs, written by Donor #15. |
Chemistry World
September 26, 2006
Ned Stafford |
Separating the Huitres From the Chaff A recent ban on French oysters has highlighted a controversy about how food should be tested for marine biotoxins. |
Chemistry World
September 26, 2006
Fiona Case |
Synchronised Delivery for DNA and Drugs Polymer capsules that can simultaneously deliver drug molecules and DNA into a cell could boost the power of cancer treatments. |
Science News
September 23, 2006
Janet Raloff |
Babies Motor Better with Breast Milk Even a few months of breastfeeding appear to confer important motor-coordination benefits on an infant. |
Chemistry World
September 21, 2006
Michael Gross |
Alzheimer's Alphabet Alzheimer's researchers are now closer to understanding the natural function of one of the two enzymes that cut A out of APP, and have recreated the process by which fibril formation begins in vivo. |
Chemistry World
September 20, 2006
Victoria Gill |
`Silent Killer' as Treatment for Heart and Lung Disease Carbon Monoxide (CO), a gas once dubbed the `silent killer' by the UK's health and safety executive, could provide a life-saving treatment for an incurable lung and heart condition, report researchers. |
Bio-IT World
September 2006
Mike May |
Working Out the Flow Better management of workflow issues in biotech and pharma could change fundamental aspects of these sciences in the near future. |
Bio-IT World
September 2006
John Russell |
IBM Races H5N1 Unlike most (perhaps all) of its IT brethren, IBM has the size and breadth of technology expertise to make waves in basic research beyond IT and to tackle global projects that enable Big Blue to do well by doing good. The Global Pandemic Initiative is a perfect example of that capacity. |
Bio-IT World
September 2006
Kevin Davies |
The $2 Billion Pill? Challenges and opportunities facing the drug industry were recurring themes in the quartet of keynote speeches at the 2006 Drug Discovery Technology conference. |
| <Older 1141-1150 Newer> Return to current articles. |
